{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:39:35Z","timestamp":1789594775225,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001205","name":"F. M. Kirby Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001205","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH T32 Predoctoral Training","award":["NS 51157-5"],"award-info":[{"award-number":["NS 51157-5"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neulet.2014.11.023","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T02:05:51Z","timestamp":1416535551000},"page":"33-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP\/p mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"585","author":[{"given":"Samantha R.","family":"Cote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldo V.","family":"Kuzhikandathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.11.023_bib0005","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2014.11.023_bib0010","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1460-9568.2000.00089.x","article-title":"Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats","volume":"12","author":"Bordet","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.neulet.2014.11.023_bib0015","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.parkreldis.2004.11.005","article-title":"Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors","volume":"11","author":"Guigoni","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2014.11.023_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2013.05.048","article-title":"Regulation of dopamine D3 receptor in the striatal regions and substantia nigra in diffuse Lewy body disease","volume":"248C","author":"Sun","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2014.11.023_bib0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.25909","article-title":"Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model","volume":"9","author":"Mahmoudi","year":"2014","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neulet.2014.11.023_bib0030","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2003.01600.x","article-title":"Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice","volume":"84","author":"Gross","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.11.023_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2014.01.011","article-title":"Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors","volume":"263","author":"Cote","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2014.11.023_bib0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00548-1","article-title":"Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa","volume":"116","author":"van Kampen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2014.11.023_bib0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.nbd.2007.04.016","article-title":"In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias","volume":"27","author":"S\u00e1nchez-Pernaute","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2014.11.023_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2008.11.010","article-title":"Dopamine D3 receptor stimulation underlies the development of l-DOPA-induced dyskinesia in animal models of Parkinson\u2019s disease","volume":"35","author":"Visanji","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2014.11.023_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuropharm.2013.11.023","article-title":"In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property","volume":"79","author":"Cote","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2014.11.023_bib0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between sub acute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"10.1016\/j.neulet.2014.11.023_bib0065","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2014.11.023_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neulet.2014.11.023_bib0075","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00429-012-0383-8","article-title":"Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model","volume":"217","author":"Li","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neulet.2014.11.023_bib0080","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1471-4159.2004.02450.x","article-title":"Multi-modal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line","volume":"89","author":"Pasuit","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2014.11.023_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","article-title":"Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease","volume":"219","author":"Meredith","year":"2009","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2014.11.023_bib0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.0408305102","article-title":"Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum","volume":"102","author":"Valjent","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.neulet.2014.11.023_bib0095","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2014.11.023_bib0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00210-012-0797-0","article-title":"Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia","volume":"386","author":"Sokoloff","year":"2013","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2014.11.023_bib0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2005.08.003","article-title":"l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"136","author":"Holmer","year":"2005","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neulet.2014.11.023_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neuron.2008.12.015","article-title":"Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII","volume":"61","author":"Liu","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neulet.2014.11.023_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2005.04190.x","article-title":"Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism","volume":"22","author":"Brown","year":"2005","journal-title":"Eur. J. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T15:22:01Z","timestamp":1538061721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014008908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":23,"alternative-id":["S0304394014008908"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.11.023","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP\/p mouse model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}